Jason Anglin

Jason joined BioTheryx as its Chief Financial Officer in October 2021. He is a Partner in CFGI’s San Francisco / Bay Area practice, providing accounting and financial consulting services with a focus in the life science and technology industries for nearly 30 years.

Jason has significant global experience having assisted clients with their most complex transactions including technical accounting (under both USGAAP and IFRS), SEC reporting, sell-side and buy-side transaction support, business combination accounting and acquisition integration. He has extensive experience assisting clients prepare for initial public offerings and debt offerings. He has led some of the most complex IPO’s including the listing of the world’s largest Ride Share Company, among others. Jason has previously worked as an audit partner, so provides unique insights into the audit process and preparation for audits.

Before joining CFGI, Jason was a Partner with KPMG, leading the West Coast accounting advisory practice, and a member of the KPMG accounting advisory global leadership team focused on acquisitions and divestitures. Jason began his career in audit and was an audit partner prior to establishing a Center of Excellence for Accounting Advisory in Latin America and joining the advisory practice, prior to relocating to the US.